Healthcare / Medical DistributionBSE
$0.27
-0.01 (-3.57%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 34% · confianza 19%
FCF escenarios
weak_data · normalized FCF $-1.3M · quality 50.0/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
29/100
D
Piotroski
3/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
16/100
SEC 0%
Sin guardar todavía.
Market Cap
$334M
P/E
1.2x
↓EV/EBITDA
44.9x
↑ROE
2.1%
↑Gross Margin
16.5%
↓Debt/Equity
1.20
↑TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2022–2025 · 3 años de histórico normalizado
Revenue CAGR
+516.1%
FCF CAGR
—
FCF margin
-904.5%
FCF / Net income
-102.32x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $245.5M · net income $21.7M · FCF $-2.22B
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $245.5M | $245.5M | — | — | $1.1M |
| Net Income | $21.7M | $21.7M | $-1.7M | $1.0M | $235793.00 |
| EBITDA | $27.9M | $27.9M | $-2.3M | $1.0M | $236475.00 |
| EPS | 0.36 | 0.36 | -0.01 | 0.01 | 0.02 |
| Gross Margin | 16.5% | 16.5% | — | — | — |
| Operating Margin | 3.9% | 3.9% | — | — | 22.5% |
| Net Margin | 8.8% | 8.8% | — | — | 22.5% |
| Balance Sheet | |||||
| Debt/Equity | 1.20 | 1.20 | — | — | — |
| Cash Flow | |||||
| Free Cash Flow | $-2.22B | $-2.22B | $-1.3M | $1.1M | $185527.00 |
| Returns | |||||
| ROE | 2.1% | 2.1% | -13.0% | 6.7% | 25.4% |
| Valuation | |||||
| P/E | 1.17 | 1.17 | — | 55.47 | 46.50 |
| EV/EBITDA | 44.90 | 44.90 | — | 53.28 | 44.87 |
| P/B | 0.02 | 0.02 | 5.02 | 3.69 | 12.12 |
| Growth & Yield | |||||
| EPS Growth | 3146.2% | 3146.2% | -273.3% | -65.9% | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
3Y implied EPS CAGR
-59.5%
EPS terminal req.
$0.02
Spread vs growth
3205.7%
5Y implied EPS CAGR
-39.6%
EPS terminal req.
$0.03
Spread vs growth
3185.8%
10Y implied EPS CAGR
-18.5%
EPS terminal req.
$0.05
Spread vs growth
3164.7%
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
-74.0%
Start / end P/E
n/dx → n/dx
EPS bridge
-0.01 → 0.36
Residual
-74.0%
EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.